Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Graziano

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
The International Journal of Biological Markers|April 18, 2003
Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancerS Aloe, R D'Alessandro, A Spila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancerS Cascinu, M P Staccioli, G Gasparini, et al.
British Journal of Haematology|January 18, 2006
Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicityLisette Bevaart, Joel Goldstein, Laura Vitale, et al.
Blood|July 26, 2003
The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphomaPeter Borchmann, John F Treml, Hinrich Hansen, et al.
Arthritis and Rheumatism|November 11, 1999
Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patientsR K Burt, C Georganas, J Schroeder, et al.
The Pharmacogenomics Journal|November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysisE K Morgen, H-J Lenz, D J Jonker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R Labianca, V Catalano, et al.
Oncoimmunology|September 22, 2017
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanismsTatiana Pazina, Ashley M James, Alexander W MacFarlane, et al.
Anticancer Research|October 30, 2004
Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trialR Mattioli, P Lippe, C Massacesi, et al.
British Journal of Cancer|June 27, 2002
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patientsF Graziano, R Bisonni, V Catalano, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
The International Journal of Biological Markers|April 18, 2003
Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancerS Aloe, R D'Alessandro, A Spila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancerS Cascinu, M P Staccioli, G Gasparini, et al.
British Journal of Haematology|January 18, 2006
Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicityLisette Bevaart, Joel Goldstein, Laura Vitale, et al.
Blood|July 26, 2003
The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphomaPeter Borchmann, John F Treml, Hinrich Hansen, et al.
Arthritis and Rheumatism|November 11, 1999
Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patientsR K Burt, C Georganas, J Schroeder, et al.
The Pharmacogenomics Journal|November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysisE K Morgen, H-J Lenz, D J Jonker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R Labianca, V Catalano, et al.
Oncoimmunology|September 22, 2017
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanismsTatiana Pazina, Ashley M James, Alexander W MacFarlane, et al.
Anticancer Research|October 30, 2004
Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trialR Mattioli, P Lippe, C Massacesi, et al.
British Journal of Cancer|June 27, 2002
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patientsF Graziano, R Bisonni, V Catalano, et al.
Pageof 17